人类癌症中微RNAs对铁亡的调节
Irena Velkova1, Martina Pasino1, Zumama Khalid2
1IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Journal of personalized medicine
|May 27, 2023
概括
微RNAs调节铁亡,这是一种细胞死亡途径,在癌症发育中至关重要. 了解微RNA如何影响铁,抗氧化剂和脂质代谢,为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 铁亡是一种受调节的细胞死亡,由于铁,抗氧化剂和脂质代谢的调节,它与瘤发生有关.
- 表观遗传变化,特别是微RNA (miRNA) 失调,是癌症的标志.
- miRNAs是癌症生长和发展的新兴调节者,影响诸如铁灭的途径.
研究的目的:
- 审查铁灭症启动的机制.
- 探索微RNAs在调节癌症中的铁亡中的作用.
- 讨论目前和潜在的新型治疗策略,以铁死为向.
主要方法:
- 关于铁亡机制和miRNA调节的文献综述.
- 使用miRBase,miRTarBase和miRecords对验证的miRNA目标进行分析.
- 鉴定参与铁代谢,脂质过氧化和抗氧化防御的基因.
主要成果:
- 确定了13个关键基因,这些基因由参与铁灭的miRNAs调节.
- miRNAs可以促进或抑制铁亡,影响癌症表型.
- 这些基因对瘤抑制和进展至关重要.
结论:
- miRNAs在控制铁亡中发挥着重要作用,影响癌症的发展.
- 通过miRNA调制向铁亡是一种有前途的癌症治疗途径.
- 对miRNA介导的铁灭菌的进一步研究可能会发现新的治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


